Celeris Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Out of Business

  • Employees
  • 23

Employees

  • Latest Deal Type
  • Out of Business

Celeris Therapeutics General Information

Description

Developer of a biotech platform intended to support the development of drugs. The company develops a platform to predict biomolecular interactions and generate small, organic molecules and degraders such as PROTACs against these targets, enabling users to use innovative methods to degrade undruggable targets.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 585 Glenwood Avenue
  • Menlo Park, CA 94025
  • United States
Primary Industry
Drug Delivery
Corporate Office
  • 585 Glenwood Avenue
  • Menlo Park, CA 94025
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Celeris Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 06-Dec-2024 Completed Out of Business
4. Early Stage VC 19-Oct-2022 Cancelled Generating Revenue
3. Grant 15-Jun-2022 Completed Generating Revenue
2. Seed Round 11-Mar-2022 $4.4M $4.4M Completed Generating Revenue
1. University Spin-Out 01-Jan-2020 Completed Startup
To view Celeris Therapeutics’s complete valuation and funding history, request access »

Celeris Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-3
Seed-2
Seed-1 946,650 $0.000100 $3.7 $3.7 1x $3.7 9.3%
To view Celeris Therapeutics’s complete cap table history, request access »

Celeris Therapeutics Patents

Celeris Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023016621-A1 Ternary complex determination for plausible targeted protein degradation using deep learning and design of degrader molecules using deep learning Inactive 12-Aug-2021

Celeris Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Celeris Therapeutics FAQs

  • When was Celeris Therapeutics founded?

    Celeris Therapeutics was founded in 2020.

  • Where is Celeris Therapeutics headquartered?

    Celeris Therapeutics is headquartered in Menlo Park, CA.

  • What is the size of Celeris Therapeutics?

    Celeris Therapeutics has 23 total employees.

  • What industry is Celeris Therapeutics in?

    Celeris Therapeutics’s primary industry is Drug Delivery.

  • Is Celeris Therapeutics a private or public company?

    Celeris Therapeutics is a Private company.

  • What is Celeris Therapeutics’s current revenue?

    The current revenue for Celeris Therapeutics is .

  • How much funding has Celeris Therapeutics raised over time?

    Celeris Therapeutics has raised $4.4M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process